Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2012
02/02/2012WO2011104555A3 Process for the preparation of sunitinib malate form i
02/02/2012WO2011102695A3 Composition for preventing or treating diseases caused by over-expression of lxrα, containing liquiritigenin or isoliquiritigenin as active ingredient
02/02/2012WO2011101367A4 Product for removing sea lice
02/02/2012WO2011094335A3 Microrna signatures predicting responsiveness to anti-her2 therapy
02/02/2012WO2011093812A3 Pharmaceutical formulation comprising tiotropium and budesonide in dry powder form
02/02/2012WO2011091065A8 Synthetic nanostructures including nucleic acids and/or other entities
02/02/2012WO2011064558A3 Pharmaceutical composition
02/02/2012WO2011063773A3 Crystalline and amorphous forms of almorexant hydrochloride and a method of their preparation
02/02/2012WO2011057973A9 Oxazoline derivatives for treatment of cns disorders
02/02/2012WO2011011077A8 Microbially stable dispersion medium for emulsions
02/02/2012WO2011005761A8 Novel nucleic acid prodrugs and methods of use thereof
02/02/2012WO2011005052A8 Novel arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same
02/02/2012WO2010146257A8 Simalikalactone e and use thereof as a medicament
02/02/2012US20120030841 Isoxazoline compounds for combating invertebrate pests
02/02/2012US20120030780 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds)
02/02/2012US20120030779 Compositions and methods for detecting, treating, or preventing reductive stress
02/02/2012US20120029475 Drug Combinations Useful for Prevention of Restenosis
02/02/2012US20120029447 Transdermal pharmaceutical preparation and administration of tirofiban
02/02/2012US20120029418 Composition and method for photodynamic disinfection
02/02/2012US20120029181 Synthesis of 5-azacytidine
02/02/2012US20120029088 Anti-anxiety composition
02/02/2012US20120029087 Use of rasagiline for the treatment of olfactory dysfunction
02/02/2012US20120029086 Compositions and Method for Temporary Reduction of Nasal and Sinus Pain
02/02/2012US20120029085 Stabilization of quinol composition such as catecholamine drugs
02/02/2012US20120029084 Topical Nepafenac Formulations
02/02/2012US20120029083 Polymorphic forms of aliskiren hemifumarate and process for preparation thereof
02/02/2012US20120029082 Nutritional or therapeutic compositions to increase bodily glutathione levels
02/02/2012US20120029081 Solid Pharmaceutical Compositions Containing Pregabalin
02/02/2012US20120029080 Reduction of risk of obesity
02/02/2012US20120029079 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
02/02/2012US20120029078 Compositions comprising myristic acid and uses thereof
02/02/2012US20120029077 Animal Feed Additive and Animal Feed Comprising Alkyl Esters of Medium Chain Fatty Acids, and their Use in Animal Feed
02/02/2012US20120029075 Compositions containing c1 to c7 organic acid monoglycerides and glycerol, their preparation and use as antibacterials and anti-mould agents
02/02/2012US20120029074 Controlling transgene expression across the skin
02/02/2012US20120029073 Pharmaceutical compositions having desirable bioavailability
02/02/2012US20120029072 Pleuromutilin derivatives for the treatment of diseases mediated by microbes
02/02/2012US20120029071 Compositions and methods for treating or preventing radiation injury
02/02/2012US20120029070 Burdock fruit extract containing arctigenin at high content and process for producing same
02/02/2012US20120029069 Compound Extracted From Antrodia Cinnamomea and Pharmaceutical composition comprising the same
02/02/2012US20120029068 Transdermal fluid
02/02/2012US20120029067 Polyphenol Proteasome Inhibitors, Synthesis, and Methods of Use
02/02/2012US20120029066 Use of flavones for treating psychiatric disorders with sensorimotor gating deficits
02/02/2012US20120029065 Compositions for treating or preventing obesity and insulin resistance disorders
02/02/2012US20120029064 formulation of silibinin with high efficacy and prolonged action and the preparation method thereof
02/02/2012US20120029062 Interior functionalized hyperbranched dendron-conjugated nanoparticles and uses thereof
02/02/2012US20120029061 Rna sequence-specific mediators of rna interference
02/02/2012US20120029060 Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof
02/02/2012US20120029059 Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof
02/02/2012US20120029058 Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof
02/02/2012US20120029057 Antisense Oligonucleotides for Inducing Exon Skipping and Methods of Use Thereof
02/02/2012US20120029056 Differentially expressed micrornas as biomarkers for the diagnosis and treatment of sjögren's syndrome
02/02/2012US20120029055 Modulators of apoptosis and the uses thereof
02/02/2012US20120029054 RNA Interference Mediated Inhibition of GATA Binding Protein 3 (GATA3) Gene Expression Using Short Intefering Nucleic Acid (siNA)
02/02/2012US20120029053 Short Interfering Ribonucleic Acid (siRNA) for Oral Administration
02/02/2012US20120029052 Short Interfering Ribonucleic Acid (siRNA) for Oral Administration
02/02/2012US20120029051 siRNA Targeting VEGFA and Methods for Treatment In Vivo
02/02/2012US20120029050 Compositions and their uses directed to diacylglycerol acyltransferase 1
02/02/2012US20120029049 Antisense Modulation of Superoxide Dismutase 1, Soluble Expression
02/02/2012US20120029048 Phenylalkyl n-hydroxyureas for treating leukotriene related pathologies
02/02/2012US20120029047 Use of hdac inhibitors for the treatment of bone destruction
02/02/2012US20120029046 Crystalline form of sunitinib and processes for its preparation
02/02/2012US20120029045 Method for treating port wine stains
02/02/2012US20120029044 7-azoniabicyclo[2.2.1]heptane derivatives, methods of production, and pharmaceutical uses thereof
02/02/2012US20120029043 Pharmaceutical Composition Containing An N-Phenylpyrazole Derivative, And Use Thereof For Preparing A Topical Veterinary For Flea Control
02/02/2012US20120029042 Clonidine for treatment of bone cancer
02/02/2012US20120029041 2-aryl imidazoline derivatives
02/02/2012US20120029037 Animal ectoparasite-controlling agent
02/02/2012US20120029036 Pharmaceutical compositions comprising pyridyl cyanoguanidine, process for preparing the same and use thereof
02/02/2012US20120029035 Compositions and methods for extended therapy with aminopyridines
02/02/2012US20120029034 Novel calcium salts of Compound as Anti-Inflammatory, Immunomodulatory and Anti-Proliferatory Agents
02/02/2012US20120029032 Matrix-type sustained release preparation containing basic additive
02/02/2012US20120029031 Metadoxine for use as inhibitor of hepatic fibrosis
02/02/2012US20120029030 Method for customized dispensing of variable dose drug combination products for individualizing of therapies
02/02/2012US20120029029 Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta hsd1 modulators
02/02/2012US20120029028 Compositions and methods for treating hyperlipidemias
02/02/2012US20120029027 N-[(6-aza-bicyclo[3.2.1]oct-5-yl)-aryl-methyl]-heterobenzamide derivatives, preparation thereof, and therapeutic use of same
02/02/2012US20120029026 Pyridine derivative
02/02/2012US20120029025 Spot-on pesticide composition
02/02/2012US20120029024 Spot-on pesticide composition
02/02/2012US20120029023 Heterocycles substituted pyridine derivatives and antifungal agent containing thereof
02/02/2012US20120029022 Potent Non-Urea Inhibitors Of Soluble Epoxide Hydrolase
02/02/2012US20120029021 Nitroxide Free Radical Synergized Antineoplastic Agents
02/02/2012US20120029020 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
02/02/2012US20120029019 Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
02/02/2012US20120029018 9-substituted phenanthrene based tylophorine derivatives
02/02/2012US20120029017 Pectin-containing jelly formulation
02/02/2012US20120029016 Indoles Useful in the Treatment of Inflammation
02/02/2012US20120029015 Novel medical use of kynurenic acid, its precursors and derivatives
02/02/2012US20120029014 5-(2--1-hydroxyethyl)-8-hydroxyquinolin-2 (1h)-one for the treatment of lung function
02/02/2012US20120029013 Derivatives of aminocyclobutane or aminocyclobutene, their method of preparation and their use as medical products
02/02/2012US20120029012 5, 6, or 7-SUBSTITUTED -3-(HETERO) ARYLISOQUINOLINAMINE DERIVATIVES AND THERAPEUTIC USE THEREOF
02/02/2012US20120029011 Novel nitrogen-containing heteroaryl compounds and methods of use thereof
02/02/2012US20120029010 Method to use compositions having antidepressant anxiolytic and other neurological activity and compositions of matter
02/02/2012US20120029009 Tacrolimus For Improved Treatment Of Transplant Patients
02/02/2012US20120029008 Crystalline and amorphous forms of nalbuphine hydrochloride
02/02/2012US20120029007 Morphinan compounds
02/02/2012US20120029006 Cis-tetrahydro-spiro(cyclohexane-1,1'-pyrido[3,4-b]indole)-4-amine Compounds
02/02/2012US20120029005 Spiperone derivatives and methods of treating disorders
02/02/2012US20120029004 Novel aminopyridine derivatives having aurora a selective inhibitory action
02/02/2012US20120029003 Galectin-3 and statin therapy
1 ... 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 ... 7860